Acute Lymphoblastic Leukemia: Challenges in MRD Testing
2 Visualizzazioni
• 08/04/23
0
0
Incorporare
administrator
Iscritti
Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti